Trial Profile
Bioequivalence and Absolute Bioavailability of a Single Oral Dose of Two Formulations of 0.75 Mg Palonosetron in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2012
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- 07 Nov 2012 New trial record